Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3161 per EA under NDC 11534018701. Its NADAC has been published 476 times since Jul 12, 2017.
FDA first approved this application on Oct 28, 2016. Its Orange Book therapeutic-equivalence code is AA.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
butalbital, acetaminophen and caffeineStrength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534018701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA207118FDA Approved
10/28/2016
TE Code
AA
On Market Since
1/10/2017
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 476 times since Jul 12, 2017, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3161 per EA |
|---|---|
| All-time high | $2.3602 (Aug 16, 2017) |
| All-time low | $0.3110 (Apr 22, 2026) |
| 52-week high | $0.4517 |
| 52-week low | $0.3110 |
| Median price | $0.6515 |
| Average price | $1.0328 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 476 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.3161 per EA (NDC 11534018701), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 86.4%. It has been tracked across 476 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Since Jul 12, 2017, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $2.3602 (Aug 16, 2017), with a median of $0.6515 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 11534018701) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.